 |
BioWorld-International-2010-04-14
Enzyme Inhibitor Offers Hope for Trypanosomiasis Treatment
Cash-Fat Vernalis to Boost Pipeline via Outside Route
LONDON — Bolstered by two fundraisings, Vernalis plc is on the hunt for a merger or acquisition that will bring an advanced and unpartnered clinical program into its pipeline. The company also is interested in in-licensing earlier-stage programs. (BioWorld International)